Type I Angiotensin II Receptor Blockade Reduces Uremia-Induced Deterioration of Bone Material Properties.
Wakamatsu T, Iwasaki Y, Yamamoto S, Matsuo K, Goto S, Narita I, Kazama JJ, Tanaka K, Ito A, Ozasa R, Nakano T, Miyakoshi C, Onishi Y, Fukuma S, Fukuhara S, Yamato H, Fukagawa M, Akizawa T.
Wakamatsu T, et al. Among authors: ozasa r.
J Bone Miner Res. 2021 Jan;36(1):67-79. doi: 10.1002/jbmr.4159. Epub 2020 Oct 2.
J Bone Miner Res. 2021.
PMID: 32786093
Free PMC article.